Aarti Drugs Share Price Zooms 9.28%: What Is Driving AARTIDRUGS Today, and the Levels That Matter

Why AARTIDRUGS is being traded today

The in focus story around Aarti Drugs (AARTIDRUGS) has the stock at ₹491.65, +9.28% on this session, with the NSE board read at 02:35 pm IST on 9 November 2026. What the tape shows: the reported percentage move is large; it does not identify its cause or predict the next quote.

The story in five lines

• Where it trades: Aarti Drugs is at ₹491.65, +41.75 (+9.28%) versus the previous close of ₹449.90.
• Why it is moving: an in-focus story — one business desk filed on the company in the last few hours.
• Today's band: ₹446.75 to ₹513.00, against an open of ₹452.80 — the stock is defending its opening print.
• Twelve-month context: 7.93% below the ₹534 high and 54.15% above the ₹319 low, so the stock sits in the upper part of its own range.
• Participation: turnover is running at 9.6x the twenty-day average, so institutions are transacting rather than retail nibbling.
• What to watch: the original company disclosure and the reporting dates of attributed sources.

Why Aarti Drugs is on the desks today

Aarti Drugs is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below. Multiple headlines indicate coverage, not independent verification or a cause of the price move.

Live price snapshot

Coverage context

Several headlines about the same company do not independently verify a development. Read the linked disclosure or attributed report; price and volume do not identify investor motives.

This is general context, not a finding about Aarti Drugs. Company-specific conclusions require the cited disclosure.

Reading today's session

Aarti Drugs's reported session range is ₹446.75 to ₹513.00, a spread of ₹66.25 (13.48% of the quoted price).

The quote of ₹491.65 is ₹38.85 above the open of ₹452.80. This comparison does not identify buyers, sellers or the cause of the move.

The headlines behind this post

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

• Aarti Drugs shares defy weak market sentiment; skyrocket 11% today | Here's why; stock returns, performance — Livemint

How the stock has performed

What the returns table is saying

Over the last week Aarti Drugs has gained +8.34% and over the month +18.76%. These are separate measurement windows; neither confirms a reversal or continuation.

The reported twelve-month return is -5.54%. Price returns alone cannot establish earnings growth, valuation changes or the cause of the move.

Reading the price against its own ranges

Over the last twelve months the reported range is ₹319 to ₹534. The quote is 80% of the way through that band, 7.93% below the high and 54.15% above the low. These are historical comparisons, not support levels or return forecasts.

Traded quantity of 1,80,45,399 shares is 9.57x the reported 20-day average of 18,84,764. An intraday reading may cover less time than a full-day average. Volume does not identify institutional activity or predict persistence of the move.

What to watch next

For this in focus story specifically, watch the original company disclosure and the reporting dates of attributed sources. On the chart, the ₹513.00 high and ₹446.75 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of that low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 18,84,764 shares to be read as positioning rather than a squeeze.

So what should shareholders do with this?

For a trader, the immediate question is not direction but whether the repricing holds. ₹513.00 and ₹446.75 are the day's markers; the next session's ability to keep the move inside that band — a higher low after an up-move, a lower high after a fall — is what separates a trend from a one-day event.

For a long-term shareholder, one session tells you very little. The stock is 7.93% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

Where that leaves the stock

Aarti Drugs is being bought on an in-focus story, and at ₹491.65 the move is backed by turnover well above its own average, which is the version of a rally that tends to hold. The day's ₹446.75–₹513.00 band is the frame for the next session, and the original company disclosure and the reporting dates of attributed sources is what resolves the story either way.

Where to track AARTIDRUGS next

Live price, charts and technicals stay on the Aarti Drugs stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Aarti Drugs share price today?

Aarti Drugs (AARTIDRUGS) last traded at ₹491.65, +41.75 (+9.28%) against the previous close of ₹449.90, read from the NSE board at 02:35 pm IST on 9 November 2026.

Why is Aarti Drugs in the news today?

1 business publisher ran headlines on the company in the last session — a in focus story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of AARTIDRUGS?

Over the last twelve months AARTIDRUGS has traded between a low of ₹319 and a high of ₹534, computed from the adjusted daily series.

Is AARTIDRUGS up or down today?

AARTIDRUGS gained +9.28% in this session, trading between ₹446.75 and ₹513.00 against an open of ₹452.80.

Reporting method

This automated report uses the sources and reporting periods cited above. Publication time may differ from the underlying quote or filing time. Provider data can be delayed or revised; missing values are unavailable, not zero. Calculated comparisons do not establish the cause of a market move.

Related live pages

• Aarti Drugs share price
• Aarti Drugs quarterly results
• Stocks in news
• Top gainers
• Market dashboard

Sources

• NSE live board data via our exchange data feed
• Headline attribution links above point to the original publishers
• TrendRipperX Aarti Drugs stock page

“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”